These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11419656)
1. Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model. Kim WG; Lee BH; Seo JW Perfusion; 2001 May; 16(3):207-14. PubMed ID: 11419656 [TBL] [Abstract][Full Text] [Related]
2. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Friedman M; Sellke FW; Wang SY; Weintraub RM; Johnson RG Circulation; 1994 Nov; 90(5 Pt 2):II262-8. PubMed ID: 7955263 [TBL] [Abstract][Full Text] [Related]
4. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass. Gu YJ; Wang YS; Chiang BY; Gao XD; Ye CX; Wildevuur CR Ann Thorac Surg; 1991 Apr; 51(4):573-8. PubMed ID: 2012415 [TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest. Cakir O; Oruc A; Kaya S; Eren N; Yildiz F; Erdinc L J Card Surg; 2004; 19(3):221-5. PubMed ID: 15151648 [TBL] [Abstract][Full Text] [Related]
7. Does sodium nitroprusside reduce lung injury under cardiopulmonary bypass? Cakir O; Oruc A; Eren S; Buyukbayram H; Erdinc L; Eren N Eur J Cardiothorac Surg; 2003 Jun; 23(6):1040-5. PubMed ID: 12829085 [TBL] [Abstract][Full Text] [Related]
8. Ultrastructural changes in the lung alveoli after cardiac surgical operations with the use of cardiopulmonary bypass (CPB). Wasowicz M; Sobczyński P; Biczysko W; Szulc R Pol J Pathol; 1999; 50(3):189-96. PubMed ID: 10624121 [TBL] [Abstract][Full Text] [Related]
13. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass. Kuratani T; Matsuda H; Sawa Y; Kaneko M; Nakano S; Kawashima Y J Thorac Cardiovasc Surg; 1992 Mar; 103(3):564-8. PubMed ID: 1545556 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition. Friedman M; Wang SY; Sellke FW; Franklin A; Weintraub RM; Johnson RG Ann Thorac Surg; 1995 Mar; 59(3):598-603. PubMed ID: 7887696 [TBL] [Abstract][Full Text] [Related]
15. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass. Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813 [TBL] [Abstract][Full Text] [Related]
16. Low-dose dopexamine's effect on lung and gut function after CPB in a sheep model. Stamler A; Wang H; Weintraub RM; Hariawala MD; Fink MP; Johnson RG J Surg Res; 1998 Feb; 74(2):165-72. PubMed ID: 9587356 [TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model. Hamamoto M; Suga M; Nakatani T; Takahashi Y; Sato Y; Inamori S; Yagihara T; Kitamura S Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290 [TBL] [Abstract][Full Text] [Related]
19. A rat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment by conductance catheter technique. Günzinger R; Wildhirt SM; Schad H; Heimisch W; Gurdan M; Mendler N; Grammer J; Lange R; Bauernschmitt R Basic Res Cardiol; 2007 Nov; 102(6):508-17. PubMed ID: 17668258 [TBL] [Abstract][Full Text] [Related]
20. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator]. Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]